Participants 385 444 4
influence of MTX on infliximab exposure in patients with AS
Participants 454 516 5
Patients with AS patients who had predominantly axial symptoms
Participants 1133 1308 3
Twenty-six patients were included (infliximab group: n = 12, infliximab + MTX group: n = 14), and 507 serum samples were available for measurement of infliximab concentration.
Participants 1546 1563 3
patients with AS.
